Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020

By afschroeder • March 7, 2026

Donohue J, Wang B, Tang L, Kim JY, Junker S, Cole E, Chang CH, Roberts E, Wilson JD, Essien U, Gifford K, Hammerslag L, Talbert J, Ahrens K, Idala D, Mohamoud S, Clark S, Austin A, Ware O, Tossone K, Mack A, Fry C, Gordon AJ, Barnes A, Marks S, Cunningham P, Allen L, Burns M, Kennedy S. Racial and ethnic differences in medications for opioid use disorder and overdose in 11 state Medicaid programs from 2016 to 2020. J Subst Use Addict Treat. 2026 Mar 4:209924. doi: 10.1016/j.josat.2026.209924. Epub ahead of print. PMID: 41791553.

Tags: buprenorphine, General Internal Medicine, medicaid, Medication for opioid-use disorder, methadone, naltrexone, Overdose, Publications, Racial/ethnic differences, Veterans Administration

Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right Atrial Rupture

Makaroff KE, Hampilos K, Sayed S, Emert B, Hu X, Nsair A, Kwon M, Middlekauff H. Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right[...]

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

Tian J, Azhir A, Decaro M, Chau N, Hügel J, Morris M, Cheng J, Fard P, Bassett IV, Bell DS, Bernstam EV, Visweswaran S, Klann[...]

Use of Evidence-Based Type 2 Diabetes Preventive Therapies and Rates of Progression to Diabetes Among Veterans with Prediabetes by Race and Ethnicity, 2010-2019

Ly DP, Washington DL, Shekelle PG, Lee ML, Moin T. Use of Evidence-Based Type 2 Diabetes Preventive Therapies and Rates of Progression to Diabetes Among[...]